| Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases R Martínez-Hernández, A Serrano-Somavilla, A Ramos-Leví, ... EBioMedicine 50, 329-342, 2019 | 35 | 2019 |
| Advances in the treatment of gastroenteropancreatic neuroendocrine carcinomas: are we moving forward? R Garcia-Carbonero, B Anton-Pascual, A Modrego, ... Endocrine Reviews 44 (4), 724-736, 2023 | 18 | 2023 |
| Oxidized lipids in the metabolic profiling of neuroendocrine tumors–Analytical challenges and biological implications Á López-López, J Godzien, B Soldevilla, A Gradillas, Á López-Gonzálvez, ... Journal of Chromatography A 1625, 461233, 2020 | 18 | 2020 |
| Comprehensive plasma metabolomic profile of patients with advanced neuroendocrine tumors (NETs). Diagnostic and biological relevance B Soldevilla, A López-López, A Lens-Pardo, C Carretero-Puche, ... Cancers 13 (11), 2634, 2021 | 10 | 2021 |
| MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms B Soldevilla, A Lens‐Pardo, P Espinosa‐Olarte, C Carretero‐Puche, ... Molecular Oncology 17 (4), 582-597, 2023 | 1 | 2023 |
| Metabolomic profile of extra-pancreatic NET: A novel prognostic tool? A La Salvia, B Soldevilla, A Lens-Pardo, A Lopez-Lopez, C Carretero, ... JOURNAL OF NEUROENDOCRINOLOGY 34, 23-23, 2022 | 1 | 2022 |
| Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival A La Salvia, A Lens-Pardo, A López-López, C Carretero-Puche, ... European Journal of Endocrinology 190 (1), 62-74, 2024 | | 2024 |
| 34P Genomic profiling of NEN patients: Prognostic and therapeutic relevance BA Pascual, A Modrego, A La Salvia, A Lens-Pardo, C Carretero-Puche, ... ESMO Open 8 (1), 2023 | | 2023 |
| 28MO Predictive biomarkers of response to axitinib in patients with advanced EP-NETs enrolled in the AXINET trial (GETNE 1107): Underlying molecular mechanisms A Lens-Pardo, C Carretero-Puche, BA Pascual, JC Castillon, M Benavent, ... ESMO Open 8 (1), 2023 | | 2023 |
| Comprehensive multiomic analysis reveals different subtypes in neuroendocrine tumors from multiple origins CC Puche, B Soldevilla, B Gil, A La Salvia, A Lens-Pardo, P Espinosa, ... Cancer Research 82 (12_Supplement), 2289-2289, 2022 | | 2022 |
| Comprehensive transcriptomic and methylomic analysis of NENs from multiple origins show subgroups of patients with clinical relevance C Carretero, B Soldevilla, B Gil, A La Salvia, A Lens-Pardo, ... JOURNAL OF NEUROENDOCRINOLOGY 34, 17-17, 2022 | | 2022 |
| Comprehensive molecular analysis of prognostic groups in Neuroendocrine Neoplasms (NENs) identifies key genes and potential regulatory mechanisms A Lens-Pardo, P Espinosa-Olarte, C Carretero, S Molina-Pinelo, C Robles, ... JOURNAL OF NEUROENDOCRINOLOGY 34, 24-24, 2022 | | 2022 |
| Comprehensive metabolomic plasma profiling identifies novel potential diagnostic biomarkers in patients with advanced neuroendocrine tumors B Soldevilla, A Lens-Pardo, A Lopez-Lopez, C Carretero-Puche, ... JOURNAL OF NEUROENDOCRINOLOGY 33, 20-20, 2021 | | 2021 |
| 1164P Prognostic value of miRNA profiling in neuroendocrine neoplasias (NENs) from lung and gastroenteropancreatic (GEP) origin P Espinosa-Olarte, B Soldevilla, C Carretero-Puche, S Molina-Pinelo, ... Annals of Oncology 31, S774-S775, 2020 | | 2020 |
| 1158MO Metabolomic profile of advanced neuroendocrine cancer patients B Soldevilla, A Lens-Pardo, A Lopez-Lopez, C Carretero-Puche, ... Annals of Oncology 31, S771-S772, 2020 | | 2020 |
